Skip to content

The effect of a pelvic floor muscle exercise program on sexual function of women during pregnancy and after delivery

The effect of a pelvic floor muscle exercise program on sexual function of women during pregnancy and after delivery: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201403013706N22
Enrollment
84
Registered
2014-04-04
Start date
2014-04-10
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maternal diseases. Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

Interventions

Intervention 1: Intervention group: Pelvic floor exercises will be done twice a day
8-12 set of contractions at each time, every set includes a strong contraction with a maximum possible power holding for 6-8 seconds followed by 3 or 4 contractions in shorter period, with a 10-second
Prevention
Intervention group: Pelvic floor exercises will be done twice a day
Control group will receive regular care and will get education on personal hygiene and care of the newborn at one session at 28- 30 weeks of gestation

Sponsors

Research deputy of Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1. Having a record at the health centres, 2. Having middle school or above education, 3. No history of previous delivery, 4. Having a single pregnancy, 5. Aged 18 to 35 years, 6. Gestational age of 17-20 weeks, 7. Permanent marriage and living with husband. Exclusion criteria: 1. Addiction to drugs and alcohol, 2. History of two or more abortions, 3. Experience of severe emotional stress within the previous three months, 4. Physical or mental diseases affected on sexual function (e.g., depression, mania, limb amputation or paralysis, the phobias, vaginusmus, 5. Taking medicines affected on sexual function (including blood pressure drugs, thiazide diuretics, anti-depressants, anti-histamines, barbiturates, narcotics, Diazepines and amphetamines, cocaine), 6. History of any pregnancy-related complications limited sexual performance according physician advice (e.g., placenta previa, cervical cerclage) 7. Underlying medical diseases (cardiovascular, gastrointestinal, respiratory, epilepsy, blood pressure), 8. Pelvic floor muscle strength of Level one or less (according to the Oxford grading criteria) or hereditary disease affecting connective tissue (such as Marfan syndrome, muscular dystrophy) or maternal abnormalities in the reproductive system, 9. Having over 12 urinary incontinence episodes per day, 10. Addiction or mental or physical problems of husband affecting on couple sexual function

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Sexual function. Timepoint: At baseline, 28-30 weeks of gestation, 3 months after delivery. Method of measurement: FSFI Questionnaire.

Secondary

MeasureTime frame
Pelvic floor muscle strength. Timepoint: At baseline, 28-30 weeks gestation, 3 months after delivery. Method of measurement: Oxford grading system.;Health-related Quality of Life. Timepoint: 28-30 weeks of gestation, 3 months after delivery. Method of measurement: Sf-36 questionnaire.;Quality of sexual life. Timepoint: 28-30 weeks of pregnancy. Method of measurement: SQOL-f Questionnaire.;Urinary Incontinence. Timepoint: 36-34 weeks of gestation, 3 months after delivery. Method of measurement: ICIQ-SF questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Pourkhiz

Midwifery Department, Faculty of Nursing & Midwifery, Tabriz University of Medical Sciences

zahra.pourkhiz@yahoo.com+98 15 1323 4278

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026